United States Securities and Exchange Commission · EDGAR Accession 0001900590-26-000003

Form C-AR

Annual Report — Regulation Crowdfunding
Campaign file 020-35836
Issuer CIK 1900590
Period 2025-12-31

AJNA BioSciences PBC

CorporationDEIncorporated 2021Littleton, COajnabiosciences.com
B

Financial Condition

two fiscal years, as filed
Revenue −48% YoYBurn increasingDebt / assets 14%16 employees
Line itemMost recent FYPrior FYΔ
Revenue1,692,7913,267,479▼ 48%
Cost of goods sold1,692,7913,267,479▼ 48%
Net income(3,800,746)(2,359,584)▼ burn
Total assets13,800,38616,627,450▼ 17%
Cash & equivalents368,4521,927,679▼ 81%
Accounts receivable00
Short-term debt1,496,442512,725▲ 192%
Long-term debt385,8191,953,013▼ 80%
Taxes paid030,000▼ 100%

Figures in USD as reported by the issuer.

C

Campaign Timeline

file 020-35836 · all filings under this campaign
Loading campaign history…